
浏览全部资源
扫码关注微信
1.天津医科大学总医院药学中心,天津 300052
2.天津市药品使用监测和临床综合评价中心,天津 300052
3.苏州大学附属第一医院药学部,江苏 苏州 215006
副主任药师,硕士。研究方向:药品临床综合评价、治疗药物监测。E-mail:duanrong2001@163.com
主任药师。研究方向:医院药学、治疗药物监测、药品临床综合评价。E-mail:13820893896@163.com
收稿:2026-01-27,
修回:2026-05-13,
录用:2026-05-14,
纸质出版:2026-05-30
移动端阅览
段蓉,缪丽燕,李正翔.基于改良德尔菲法的《治疗药物监测管理指南》研究问题体系 构建 Δ[J].中国药房,2026,37(10):1241-1245. DOI: 10.6039/j.issn.1001-0408.2026.10.01.
DUAN Rong,MIAO Liyan,LI Zhengxiang.Construction of the research question system of the Guideline for the Management of Therapeutic Drug Monitoring based on modified Delphi method[J].ZHONGGUO YAOFANG,2026,37(10):1241-1245.
段蓉,缪丽燕,李正翔.基于改良德尔菲法的《治疗药物监测管理指南》研究问题体系 构建 Δ[J].中国药房,2026,37(10):1241-1245. DOI: 10.6039/j.issn.1001-0408.2026.10.01. DOI:
DUAN Rong,MIAO Liyan,LI Zhengxiang.Construction of the research question system of the Guideline for the Management of Therapeutic Drug Monitoring based on modified Delphi method[J].ZHONGGUO YAOFANG,2026,37(10):1241-1245. DOI: 10.6039/j.issn.1001-0408.2026.10.01.
目的
2
构建《治疗药物监测管理指南》(以下简称《指南》)的研究问题体系,为《指南》的制定提供依据。
方法
2
在文献研究和专家访谈的基础上,初步构建《指南》研究问题调查问卷,通过改良德尔菲法对《指南》制定专家进行线上问卷调研并召开专家共识会议,确定《指南》研究问题体系。
结果
2
共发放调研问卷59份,回收有效问卷52份,专家积极系数为88.14%。纳入专家来自21个省/自治区/直辖市,涵盖治疗药物监测相关多学科专家,均具有高级专业技术职称。调研专家经过一轮调研即对研究问题达成共识,形成了涵盖治疗药物监测开展指征(4个一级研究问题、10个二级研究问题、31个三级研究问题)、治疗药物监测技术流程(3个一级研究问题、9个二级研究问题、13个三级研究问题)、结果解读及临床应用(3个一级研究问题、3个二级研究问题)、质量控制(8个一级研究问题、12个二级研究问题)4个板块的研究问题体系。4个板块的重要性评分为4.71~4.88分,满分率均不低于73.08%,专家权威系数均不低于0.90,重要性评分变异系数均不高于0.11,肯德尔协调系数
W
为0.464~0.626(
P
均小于0.05)。
结论
2
构建的研究问题体系具有较高的权威性、科学性和可靠性,可为《指南》标准化制定奠定基础。
OBJECTIVE
2
To construct a research question system of the
Guideline for the Management of Therapeutic Drug Monitoring
(hereinafter referred to as the
Guideline
), so as to provide the basis for the formulation of the
Guideline
.
METHODS
2
Based on literature research and expert interviews, the questionnaire about research questions of the
Guideline
was initially constructed. Through the modified Delphi method, the online questionnaire survey and expert consensus meeting were conducted among the
Guideline
development experts to determine the research question system of the
Guideline
.
RESULTS
2
A total of 59 questionnaires were distributed, and 52 valid questionnaires were collected. The positive coefficient of experts was 88.14%. The experts came from 21 provinces/autonomous regions/municipalities directly under the central government, covering multidisciplinary experts related to therapeutic drug monitoring, all of whom held senior professional titles. After one round of survey, a consensus was reached on the research questions, and a research question framework encompassing four research parts was constructed, including: indications for conducting therapeutic drug monitoring (4 first-level research questions,10 second-level research questions, 31 third-level research questions); therapeutic drug monitoring technical process (3 first-level research questions, 9 second-level research questions, 13 third-level research questions); result interpretation and clinical application (3 first-level research questions and 3 second-level research questions); quality control (8 first-level research questions and 12 second-level research questions). The importance scores for the four parts ranged from 4.71 to 4.88, with full-score rates all no less than 73.08%. The expert authori
ty coefficients were all no less than 0.90, the coefficients of variation of importance scores were all no higher than 0.11, and Kendall’s
W
ranged from 0.464 to 0.626 (all
P
<0.05).
CONCLUSIONS
2
The constructed research question system has high authority, scientificity, and reliability, laying a foundation for the standardized formulation of the
Guideline
.
刘燕 , 刘丹 , 黄亮 , 等 . 近30年治疗药物监测的趋势与热点:基于CiteSpace的可视化分析 [J ] . 中国医院药学杂志 , 2022 , 42 ( 12 ): 1207 - 1213 .
宋帅 , 刘加涛 , 苏涌 , 等 . 安徽省二级以上医院治疗药物监测工作开展现状的调研分析 [J ] . 中国医院药学杂志 , 2023 , 43 ( 22 ): 2558 - 2564 .
ZHOU W Y , DENG Y H , ZHANG C , et al . Current status of therapeutic drug monitoring for methotrexate,imatinib,paclitaxel in China [J ] . Clin Biochem , 2022 , 104 : 44 - 50 .
李正翔 , 缪丽燕 , 段蓉 . 《治疗药物监测技术管理指南》计划书 [J ] . 中国医院药学杂志 , 2025 , 45 ( 10 ): 1089 - 1093 .
杨克虎 . 世界卫生组织指南制定手册 [M ] . 兰州 : 兰州大学出版社 , 2013 : 41 - 64 .
SINCLAIR D , ISBA R , KREDO T , et al . World Health Organization guideline development:an evaluation [J ] . PLoS One , 2013 , 8 ( 5 ): e63715 .
成梓欣 , 高颖 , 秦明臻 , 等 . 改良德尔菲法在中成药专家共识临床问题清单确立中的应用 [J ] . 现代中医临床 , 2025 , 32 ( 3 ): 56 - 61 .
段蓉 , 李正翔 . 基于德尔菲法和层次分析法构建《药品临床综合评价主题遴选指南》研究问题及主题遴选评估指标体系 [J ] . 中国药房 , 2025 , 36 ( 7 ): 789 - 793 .
刘爽 , 姜丹 , 赵荣生 . 基于德尔菲法确定霉酚酸治疗药物监测指南的临床问题与结局指标 [J ] . 中国医院药学杂志 , 2022 , 42 ( 14 ): 1479 - 1482 .
0
浏览量
43
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621